Xenetic (XBIO) Biosciences has extended its previously announced Research Funding and Option Agreement with The Scripps Research Institute to advance the development of the Company’s program on the ...

Company is advancing DNase-based oncology program towards clinical proof-of-concept studies in multiple indications FRAMINGHAM, MA / ACCESSWIRE / November 7, 2024 / Xenetic Biosciences, Inc.

UC San Diego's Scripps Institution of Oceanography Tuesday was awarded a five-year, $40 million award from the U.S. Army Corps of Engineers for a coastal research and monitoring program.

Using stem cells generated from patients with a rare and severe form of autism spectrum disorder and intellectual disability, Scripps Research scientists have grown personalized "mini-brains" (or ...

The Scripps Research Center, a La Jolla-based research institution committed to advancing human health through profound ...

FRAMINGHAM, MA / ACCESSWIRE / November 7, 2024 / Xenetic Biosciences, Inc. (NASDAQ:XBIO) ("Xenetic" or the "Company"), a biopharmaceutical company focused on advancing innovative immuno-oncology ...

Company is advancing DNase-based oncology program towards clinical proof-of-concept studies in multiple indications FRAMINGHAM, MA / ACCESSWIRE / November 7, 2024 / Xenetic Biosciences, Inc ...

scientists at Scripps Research and its nonprofit drug development arm, the Calibr-Skaggs Institute for Innovative Medicines, are advancing novel regenerative medicines capable of repairing tissues ...

Michael Bollong, PhD, Associate Chemistry Professor at Scripps Research, joined Fox 5 to talk more about Scripps Research advancing breakthrough regenerative medicines to reverse aging-related ...

Zeit Aktuelle Nachrichten Do Xenetic Biosciences, Inc. Extends Research and Development Collaboration with The Scripps Research Institute to Advance DNase Platform Company is advancing DNase-based ...